⌘K

Login Start Free

Home/Insiders/Maizel Ari

MA

SEC Insider//CIK 0002042289

Maizel Ari

CIK 00020422891 companyNEW YORK, NY

Transactions

11

Companies

1

Filings

5

CIK

0002042289

Recent Transactions

11 trades

Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2026-04-22$70.73/sh+7,500→ 7,500 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2026-04-22−7,500→ 23,710 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2026-04-22$182.42/sh−7,500→ 0 total
Award
Axsome Therapeutics, Inc.$AXSM
Performance Stock Units
2026-04-21+7,224→ 7,224 total
Award
Axsome Therapeutics, Inc.$AXSM
Restricted Stock Units
2026-02-26+16,385→ 16,385 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Stock Option (Right to Buy)
2026-01-21−7,500→ 31,210 total
Exercise/Conversion
Axsome Therapeutics, Inc.$AXSM
Common Stock
2026-01-21$70.73/sh+7,500→ 7,500 total
Sale
Axsome Therapeutics, Inc.$AXSM
Common Stock
2026-01-21$184.44/sh−7,500→ 0 total
Award
Axsome Therapeutics, Inc.$AXSM
Performance Stock Units
2025-02-24+7,740→ 7,740 total
Award
Axsome Therapeutics, Inc.$AXSM
Employee Stock Option (Right to Buy)
2025-02-21+7,816→ 7,816 total
Award
Axsome Therapeutics, Inc.$AXSM
Restricted Stock Units
2025-02-21+7,740→ 7,740 total

Companies

1

Axsome Therapeutics, Inc.
Chief Commercial Officer
$AXSM

Recent Filings

5

Address

C/O AXSOME THERAPEUTICS, INC. ONE WORLD TRADE CENTER, 29TH FLOOR

NEW YORK, NY, 10007

View on SEC.gov